584 related articles for article (PubMed ID: 35990654)
1. Modes of action and diagnostic value of miRNAs in sepsis.
Antonakos N; Gilbert C; Théroude C; Schrijver IT; Roger T
Front Immunol; 2022; 13():951798. PubMed ID: 35990654
[TBL] [Abstract][Full Text] [Related]
2. New Definitions of Sepsis and the Quest for Specific Biomarkers. Are the miRNAs the Answer?
Manga G; Calin GA; Manuc M; Droc G; Tudor S
Chirurgia (Bucur); 2018; 113(4):464-468. PubMed ID: 30183576
[TBL] [Abstract][Full Text] [Related]
3. Identification of microRNA as sepsis biomarker based on miRNAs regulatory network analysis.
Huang J; Sun Z; Yan W; Zhu Y; Lin Y; Chen J; Shen B; Wang J
Biomed Res Int; 2014; 2014():594350. PubMed ID: 24809055
[TBL] [Abstract][Full Text] [Related]
4. Use of miRNAs as biomarkers in sepsis.
Dumache R; Rogobete AF; Bedreag OH; Sarandan M; Cradigati AC; Papurica M; Dumbuleu CM; Nartita R; Sandesc D
Anal Cell Pathol (Amst); 2015; 2015():186716. PubMed ID: 26221578
[TBL] [Abstract][Full Text] [Related]
5. Expression of MicroRNAs in Sepsis-Related Organ Dysfunction: A Systematic Review.
Maiese A; Scatena A; Costantino A; Chiti E; Occhipinti C; La Russa R; Di Paolo M; Turillazzi E; Frati P; Fineschi V
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012630
[TBL] [Abstract][Full Text] [Related]
6. Circulating Plasma microRNAs can differentiate Human Sepsis and Systemic Inflammatory Response Syndrome (SIRS).
Caserta S; Kern F; Cohen J; Drage S; Newbury SF; Llewelyn MJ
Sci Rep; 2016 Jun; 6():28006. PubMed ID: 27320175
[TBL] [Abstract][Full Text] [Related]
7. Circulating MicroRNAs as Biomarkers for Sepsis.
Benz F; Roy S; Trautwein C; Roderburg C; Luedde T
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26761003
[TBL] [Abstract][Full Text] [Related]
8. Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy.
Horiguchi H; Loftus TJ; Hawkins RB; Raymond SL; Stortz JA; Hollen MK; Weiss BP; Miller ES; Bihorac A; Larson SD; Mohr AM; Brakenridge SC; Tsujimoto H; Ueno H; Moore FA; Moldawer LL; Efron PA;
Front Immunol; 2018; 9():595. PubMed ID: 29670613
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
Patil NK; Bohannon JK; Sherwood ER
Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
[TBL] [Abstract][Full Text] [Related]
10. Role of miRNA dysregulation in sepsis.
Formosa A; Turgeon P; Dos Santos CC
Mol Med; 2022 Aug; 28(1):99. PubMed ID: 35986237
[TBL] [Abstract][Full Text] [Related]
11. Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications.
Giza DE; Fuentes-Mattei E; Bullock MD; Tudor S; Goblirsch MJ; Fabbri M; Lupu F; Yeung SJ; Vasilescu C; Calin GA
Cell Death Differ; 2016 Dec; 23(12):1906-1918. PubMed ID: 27740627
[TBL] [Abstract][Full Text] [Related]
12. Cellular and extracellular miRNAs are blood-compartment-specific diagnostic targets in sepsis.
Reithmair M; Buschmann D; Märte M; Kirchner B; Hagl D; Kaufmann I; Pfob M; Chouker A; Steinlein OK; Pfaffl MW; Schelling G
J Cell Mol Med; 2017 Oct; 21(10):2403-2411. PubMed ID: 28382754
[TBL] [Abstract][Full Text] [Related]
13. Role of microRNAs As Biomarkers in Sepsis-Associated Encephalopathy.
Osca-Verdegal R; Beltrán-García J; Pallardó FV; García-Giménez JL
Mol Neurobiol; 2021 Sep; 58(9):4682-4693. PubMed ID: 34160774
[TBL] [Abstract][Full Text] [Related]
14. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
15. Opioids and Sepsis: Elucidating the Role of the Microbiome and microRNA-146.
Abu Y; Vitari N; Yan Y; Roy S
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163021
[TBL] [Abstract][Full Text] [Related]
16. Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression?
Winkler MS; Rissiek A; Priefler M; Schwedhelm E; Robbe L; Bauer A; Zahrte C; Zoellner C; Kluge S; Nierhaus A
PLoS One; 2017; 12(8):e0182427. PubMed ID: 28771573
[TBL] [Abstract][Full Text] [Related]
17. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
18. Sepsis: network pathophysiology and implications for early diagnosis.
Arora J; Mendelson AA; Fox-Robichaud A
Am J Physiol Regul Integr Comp Physiol; 2023 May; 324(5):R613-R624. PubMed ID: 36878489
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the circulating microRNA hsa-let-7d-3p as a potential new biomarker for sepsis in human subjects.
Zhang Z; Luo H; Li C; Liang Z
Eur J Med Res; 2022 Jul; 27(1):137. PubMed ID: 35907902
[TBL] [Abstract][Full Text] [Related]
20. Role of sepsis modulated circulating microRNAs.
Szilágyi B; Fejes Z; Pócsi M; Kappelmayer J; Nagy B
EJIFCC; 2019 Jun; 30(2):128-145. PubMed ID: 31263389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
